The unique perspective children have on life is what inspired me to pursue pediatrics following medical school. Working with children brings so much joy and fun to my day, and I similarly want my patients to look forward to our appointments. I also want all who come to my office to view their visits as an opportunity to be heard and have autonomy in their care. My commitment to my patients and families is to find improvement for their health in as many different ways as possible.
I value innovation and change in healthcare, especially when it comes to how care is delivered. My team and I are studying the impact of chronic pulmonary diseases on sleep and mental health. We are also evaluating novel healthcare delivery applications and technological innovations to improve the healthcare system. Lastly, we are aiming to understand how different diseases may impact school outcomes, transitions to adult care and long-term health needs.
Through our ongoing research and clinical care, our goal is to find better ways to support the health and wellness of the people we care for every day.
MD: The Ohio State University College of Medicine, Columbus, OH, 2013.
Residency: Nationwide Children's Hospital, Columbus, OH, 2016.
Fellowship: Pediatric Pulmonology, Nationwide Children's Hospital, Columbus, OH, 2019; Sleep Medicine, The Ohio State University Wexner Medical Center/Nationwide Children's Hospital, Columbus, OH, 2020.
Master's in Medical Management: Carnegie Mellon University, Pittsburgh, PA, 2025.
Obstructive sleep apnea; sleep disorders; cystic fibrosis
Improving educational and behavioral health outcomes in various pediatric pulmonary and sleep disorders; improving clinical quality and care access within digital health platforms and learning laboratory environments
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Growth, Body Composition, and Strength of Children With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor (ETI). Pediatric Pulmonology. 2025; 60:e27463.
Improving implementation and team communication by integrating a cystic fibrosis transition readiness (CF R.I.S.E.) program into electronic health records. Pediatric Pulmonology. 2025; 60:e27326.
161 Is a multidisciplinary, family-focused intervention to improve BMI, body composition, and related functions for preadolescents treated with elexacaftor/tezacaftor/ivacaftor feasible?. Journal of Cystic Fibrosis. 2024; 23:s90.
555 School is in session: development of a comprehensive toolkit for care teams to support school success. Journal of Cystic Fibrosis. 2024; 23:s306.
779 Transition: a multidisciplinary approach. Journal of Cystic Fibrosis. 2024; 23:s448.
Body composition in children with cystic fibrosis treated with CFTR modulators versus modulator naïve individuals. Pediatric Pulmonology. 2024; 59:805-808.
Education-related needs for children with cystic fibrosis: Perspectives of US pediatric care teams. Pediatric Pulmonology. 2024; 59:95-100.
Cystic Fibrosis. Pediatric Rotations. : Springer Nature; Springer Nature; 2024.
Longitudinal mental health trends in cystic fibrosis. Journal of Cystic Fibrosis. 2023; 22:1093-1099.
123 Rates of change in growth, body composition, muscle strength, and FEV1 during elexacaftor-tezacaftor-ivacaftor therapy for 6- to 11-yearold children. Journal of Cystic Fibrosis. 2023; 22:s64-s65.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey